1. Home
  2. NVCT vs SPE Comparison

NVCT vs SPE Comparison

Compare NVCT & SPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • SPE
  • Stock Information
  • Founded
  • NVCT 2020
  • SPE 1993
  • Country
  • NVCT United States
  • SPE United States
  • Employees
  • NVCT N/A
  • SPE N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • SPE Finance/Investors Services
  • Sector
  • NVCT Health Care
  • SPE Finance
  • Exchange
  • NVCT Nasdaq
  • SPE Nasdaq
  • Market Cap
  • NVCT 167.0M
  • SPE 166.0M
  • IPO Year
  • NVCT 2022
  • SPE N/A
  • Fundamental
  • Price
  • NVCT $6.71
  • SPE $15.20
  • Analyst Decision
  • NVCT Strong Buy
  • SPE
  • Analyst Count
  • NVCT 3
  • SPE 0
  • Target Price
  • NVCT $15.33
  • SPE N/A
  • AVG Volume (30 Days)
  • NVCT 114.1K
  • SPE 25.4K
  • Earning Date
  • NVCT 11-05-2025
  • SPE 01-01-0001
  • Dividend Yield
  • NVCT N/A
  • SPE 8.55%
  • EPS Growth
  • NVCT N/A
  • SPE N/A
  • EPS
  • NVCT N/A
  • SPE N/A
  • Revenue
  • NVCT N/A
  • SPE N/A
  • Revenue This Year
  • NVCT N/A
  • SPE N/A
  • Revenue Next Year
  • NVCT N/A
  • SPE N/A
  • P/E Ratio
  • NVCT N/A
  • SPE N/A
  • Revenue Growth
  • NVCT N/A
  • SPE N/A
  • 52 Week Low
  • NVCT $4.44
  • SPE $10.26
  • 52 Week High
  • NVCT $11.80
  • SPE $12.59
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 61.14
  • SPE 41.21
  • Support Level
  • NVCT $5.61
  • SPE $15.18
  • Resistance Level
  • NVCT $7.00
  • SPE $15.46
  • Average True Range (ATR)
  • NVCT 0.34
  • SPE 0.20
  • MACD
  • NVCT 0.09
  • SPE -0.01
  • Stochastic Oscillator
  • NVCT 79.14
  • SPE 11.37

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

Share on Social Networks: